Suppr超能文献

吲达帕胺和卡托普利对自发性高血压发展影响的比较。

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

作者信息

Vranková Stanislava, Jendekova Lydia, Paulis Ludovit, Sladkova Martina, Simko Fedor, Pechanova Olga

机构信息

Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, Bratislava, Slovak Republic.

出版信息

J Hypertens Suppl. 2009 Aug;27(6):S42-6. doi: 10.1097/01.hjh.0000358837.64052.0a.

Abstract

OBJECTIVES

The effects of indapamide, a thiazide-like diuretic, and captopril, an angiotensin-converting enzyme inhibitor, on spontaneous hypertension and the development of left ventricular hypertrophy (LVH), nitric oxide generation and oxidant status were investigated.

METHODS

Six-week-old male spontaneously hypertensive rats (SHR) were treated with indapamide (1 mg/kg per day) or captopril (10 mg/kg per day) or a combination of indapamide plus captopril. After the 6-week treatment, nitric oxide synthase (NOS) activity, the expression of NOS isoform proteins, conjugated dienes concentration and relaxation responses of the femoral artery were analyzed.

RESULTS

Indapamide and captopril partly prevented a blood pressure increase in young SHR. Captopril in contrast to indapamide reduced LVH. The effect of the combined indapamide and captopril treatment on the prevention of hypertension was additive. Combined indapamide and captopril treatment increased NOS activity and endothelial NOS protein expression in the aorta and decreased conjugated dienes concentration in the kidney compared with the indapamide monotherapy group. Indapamide and indapamide and captopril treatment increased acetylcholine-induced relaxation of the femoral artery.

CONCLUSION

Whereas captopril reduced LVH, indapamide enhanced NOS activity and decreased oxidative damage in the case of the combined treatment. It is concluded that the complex protective effects of the combined indapamide plus captopril treatment on hypertension may be exerted via its effects on blood pressure, hypertrophy and vasorelaxation.

摘要

目的

研究类噻嗪利尿剂吲达帕胺和血管紧张素转换酶抑制剂卡托普利对自发性高血压及左心室肥厚(LVH)发展、一氧化氮生成和氧化状态的影响。

方法

对六周龄雄性自发性高血压大鼠(SHR)给予吲达帕胺(每日1毫克/千克)或卡托普利(每日10毫克/千克)或吲达帕胺加卡托普利联合治疗。六周治疗后,分析一氧化氮合酶(NOS)活性、NOS同工型蛋白表达、共轭二烯浓度及股动脉舒张反应。

结果

吲达帕胺和卡托普利部分阻止了年轻SHR血压升高。与吲达帕胺相比,卡托普利减轻了LVH。吲达帕胺和卡托普利联合治疗预防高血压的效果具有相加性。与吲达帕胺单药治疗组相比,吲达帕胺和卡托普利联合治疗增加了主动脉中NOS活性和内皮型NOS蛋白表达,并降低了肾脏中共轭二烯浓度。吲达帕胺以及吲达帕胺和卡托普利治疗增加了乙酰胆碱诱导的股动脉舒张。

结论

在联合治疗中,卡托普利减轻了LVH,而吲达帕胺增强了NOS活性并减少了氧化损伤。得出结论,吲达帕胺加卡托普利联合治疗对高血压的复杂保护作用可能是通过其对血压、肥厚和血管舒张的影响来发挥的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验